Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-04-26 07:08 | English | 435.5 KB | |||
| 2012-04-18 08:38 |
Pharming launches free investor relations app
|
English | 161.6 KB | ||
| 2012-04-11 08:41 |
Pharming redeems fourth tranche of convertible bond
|
English | 162.2 KB | ||
| 2012-04-02 18:18 | English | 5.6 MB | |||
| 2012-03-26 07:43 |
PHARMING AND HYUPJIN CORPORATION ANNOUNCE COMMERCIALISATION AGREEMENT FOR RUCON…
|
English | 155.5 KB | ||
| 2012-03-12 08:53 |
Pharming redeems third tranche of convertible bond
|
English | 166.6 KB | ||
| 2012-03-08 08:34 |
Pharming to present at Roth Growth Conference on March 12, 2012
|
English | 173.8 KB | ||
| 2012-03-01 08:18 |
Pharming announces preliminary financial results 2011
|
English | 269.8 KB | ||
| 2012-02-14 08:29 |
Pharming and Transmedic announce distribution agreement for Ruconest
|
English | 167.3 KB | ||
| 2012-02-10 08:34 |
Pharming announces initiation of a pediatric phase II clinical study with Rucon…
|
English | 166.2 KB | ||
| 2012-02-09 08:46 |
Pharming redeems second tranche of convertible bond
|
English | 160.7 KB | ||
| 2012-02-03 17:08 |
Pharming reports on Extraordinary General Meeting of Shareholders
|
English | 166.6 KB | ||
| 2012-01-24 08:28 |
New data published on Ruconest's effect on blood clotting parameters
|
English | 186.3 KB | ||
| 2012-01-06 08:41 |
Pharming redeems part of convertible bond
|
English | 238.6 KB | ||
| 2011-12-23 08:19 |
PHARMING ANNOUNCES €8.4 MILLION CONVERTIBLE BOND FINANCING
|
English | 230.7 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
